AEON.WS

AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS

Overview Fund Activity
Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

42 hedge funds and large institutions have $572K invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-7
Holders Change %
-14.29%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
7
Closed
10
Calls
$19K
Puts
$66K
Net Calls
-$47K
Net Calls Change
-$399K

Top Buyers

1
SIM
Sandia Investment Management
Massachusetts
$8.77K
2
LOAMU
Lombard Odier Asset Management (USA)
New York
$3.75K
3
CAC
Cowen and Company
New York
$27.7K
4
VF
Virtu Financial
New York
$2K
5
SSA
Schonfeld Strategic Advisors
New York
$2.7K

Top Sellers

1
AC
Athos Capital
Hong Kong
$0
2
SCM
Shaolin Capital Management
Florida
$0
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
$43.5K
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
$0
5
CH
CVI Holdings
Delaware
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EH
51
EMG Holdings
Connecticut
– -$1.38K -24,999 Closed
AA
52
Ancora Advisors
Ohio
– -$307 -5,589 Closed
1 2
3